Literature DB >> 7608797

Early immunization with inactivated poliovirus vaccine in premature infants.

N Linder1, M Yaron, R Handsher, J Kuint, E Birenbaum, R Mazkereth, D Lubin, E Mendelson, O Safrir, B Reichman.   

Abstract

The antibody titers of 41 premature infants receiving inactivated poliovirus vaccine at 2 months of age (control group) were compared with titers of 39 infants receiving an additional dose at 5 to 10 days of age (study group). At 1 month of age 97.4% of the study group but only 70.8% of the control group had protective antibodies against poliovirus 3 (p < 0.001).

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7608797     DOI： 10.1016/s0022-3476(95)70272-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  5 in total

Review 1.  Oral and inactivated poliovirus vaccines in the newborn: a review.

Authors:  Farrah J Mateen; Russell T Shinohara; Roland W Sutter
Journal:  Vaccine       Date:  2012-06-20       Impact factor: 3.641

Review 2.  Immunisation of premature infants.

Authors:  J Bonhoeffer; C-A Siegrist; P T Heath
Journal:  Arch Dis Child       Date:  2006-11       Impact factor: 3.791

3.  Controlled trial of immune response of preterm infants to recombinant hepatitis B and inactivated poliovirus vaccines administered simultaneously shortly after birth.

Authors:  N Linder; R Handsher; B German; L Sirota; M Bachman; S Zinger; E Mendelson; A Barzilai
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-07       Impact factor: 5.747

4.  Immunogenicity of hepatitis B vaccine in preterm infants.

Authors:  O Blondheim; D Bader; M Abend; M Peniakov; D Reich; I Potesman; R Handsher; I Gidoni; N Linder
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-11       Impact factor: 5.747

5.  Hib vaccination in infants born prematurely.

Authors:  P T Heath; R Booy; J McVernon; J Bowen-Morris; H Griffiths; M P E Slack; A C Moloney; M E Ramsay; E R Moxon
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.